Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities Sean G. Rudd Review Article Open access 15 July 2023 Pages: 241 - 251
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs Xiaowen WangFang ChenBing Han Review Article 19 July 2023 Pages: 253 - 270
Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis Takuya KanekoKosuke DokiMasato Homma Original Article 17 July 2023 Pages: 271 - 278
Clinical implications and chemo-sensitivity of adjuvant chemotherapy in patients with poorly cohesive cells-gastric cancer Jin Ho BaekByung Woog KangJong Gwang Kim Original Article 22 July 2023 Pages: 279 - 290
Azithromycin inhibits glioblastoma angiogenesis in mice via inducing mitochondrial dysfunction and oxidative stress Xiulan ZhangHaibo Xu Original Article 24 July 2023 Pages: 291 - 302
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma Hidemi NishiKunihito GotohHidetoshi Eguchi Original Article Open access 26 July 2023 Pages: 303 - 314
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic–pharmacokinetic and exposure–response analysis Hayato YokotaKazuhiro SatoMasatomo Miura Original Article 27 July 2023 Pages: 315 - 324
Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report Shelby BarnettAye Chan NyeinGareth J. Veal Short Communication Open access 15 July 2023 Pages: 325 - 328